BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18186103)

  • 1. Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research.
    Steward WP; Gescher AJ
    Mol Nutr Food Res; 2008 Sep; 52(9):1005-9. PubMed ID: 18186103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies.
    Epstein J; Sanderson IR; Macdonald TT
    Br J Nutr; 2010 Jun; 103(11):1545-57. PubMed ID: 20100380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
    Shehzad A; Wahid F; Lee YS
    Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New mechanisms and therapeutic potential of curcumin for colorectal cancer.
    Villegas I; Sánchez-Fidalgo S; Alarcón de la Lastra C
    Mol Nutr Food Res; 2008 Sep; 52(9):1040-61. PubMed ID: 18655004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin for chemoprevention of colon cancer.
    Johnson JJ; Mukhtar H
    Cancer Lett; 2007 Oct; 255(2):170-81. PubMed ID: 17448598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 427():1-275. PubMed ID: 12616304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-targeted therapy by curcumin: how spicy is it?
    Goel A; Jhurani S; Aggarwal BB
    Mol Nutr Food Res; 2008 Sep; 52(9):1010-30. PubMed ID: 18384098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship of C5-curcuminoids and synthesis of their molecular probes thereof.
    Yamakoshi H; Ohori H; Kudo C; Sato A; Kanoh N; Ishioka C; Shibata H; Iwabuchi Y
    Bioorg Med Chem; 2010 Feb; 18(3):1083-92. PubMed ID: 20060305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin and its analogues: potential anticancer agents.
    Agrawal DK; Mishra PK
    Med Res Rev; 2010 Sep; 30(5):818-60. PubMed ID: 20027668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of curcumin in cancer therapy.
    Shishodia S; Chaturvedi MM; Aggarwal BB
    Curr Probl Cancer; 2007; 31(4):243-305. PubMed ID: 17645940
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin.
    Yadav B; Taurin S; Rosengren RJ; Schumacher M; Diederich M; Somers-Edgar TJ; Larsen L
    Bioorg Med Chem; 2010 Sep; 18(18):6701-7. PubMed ID: 20728364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin and cancer: an "old-age" disease with an "age-old" solution.
    Anand P; Sundaram C; Jhurani S; Kunnumakkara AB; Aggarwal BB
    Cancer Lett; 2008 Aug; 267(1):133-64. PubMed ID: 18462866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin as "Curecumin": from kitchen to clinic.
    Goel A; Kunnumakkara AB; Aggarwal BB
    Biochem Pharmacol; 2008 Feb; 75(4):787-809. PubMed ID: 17900536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer potential of curcumin: preclinical and clinical studies.
    Aggarwal BB; Kumar A; Bharti AC
    Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin and the cellular stress response in free radical-related diseases.
    Calabrese V; Bates TE; Mancuso C; Cornelius C; Ventimiglia B; Cambria MT; Di Renzo L; De Lorenzo A; Dinkova-Kostova AT
    Mol Nutr Food Res; 2008 Sep; 52(9):1062-73. PubMed ID: 18792015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship studies of curcumin analogues.
    Fuchs JR; Pandit B; Bhasin D; Etter JP; Regan N; Abdelhamid D; Li C; Lin J; Li PK
    Bioorg Med Chem Lett; 2009 Apr; 19(7):2065-9. PubMed ID: 19249204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.
    Allegra A; Innao V; Russo S; Gerace D; Alonci A; Musolino C
    Cancer Invest; 2017 Jan; 35(1):1-22. PubMed ID: 27996308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.
    Sharma RA; McLelland HR; Hill KA; Ireson CR; Euden SA; Manson MM; Pirmohamed M; Marnett LJ; Gescher AJ; Steward WP
    Clin Cancer Res; 2001 Jul; 7(7):1894-900. PubMed ID: 11448902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.
    Kunnumakkara AB; Anand P; Aggarwal BB
    Cancer Lett; 2008 Oct; 269(2):199-225. PubMed ID: 18479807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.